Botanical guide · Ingredient reference

Shark cartilage: cancer claims and disappointing clinical results

Why antiangiogenic laboratory findings did not establish a cancer treatment benefit.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the research addresses

Shark cartilage has been promoted for cancer and other conditions. MSK describes laboratory antiangiogenic activity but unsatisfactory cancer-trial outcomes. A purified extract, AE-941, did not improve survival in a lung-cancer study; laboratory activity alone is not evidence of patient benefit. [1]

What the finding does not establish

A purified investigational extract and a retail cartilage supplement are different products. Varying composition also prevents a retail brand from borrowing every finding obtained with an experimental preparation. [1]

Follow the claim all the way to the patient outcome

Suppose an extract affects blood-vessel formation in a model. That may justify clinical investigation, but an actual treatment claim needs evidence that patients benefit. If a later trial fails to improve survival, repeating the earlier mechanism does not make that clinical result disappear.

Also ask whether a product contains the tested preparation. “Shark cartilage” describes a source material, not a guarantee of a specific composition. A persuasive comparison would name the extract and measured outcome, while acknowledging negative trials rather than placing them outside the advertising story.

Hypothetical example — illustrates evidence interpretation; not a product or dose recommendation.
Hypothetical finding or choiceWhat it means
A laboratory antiangiogenic effectA hypothesis for clinical testing
No survival gain in a trialA result that limits the treatment claim
A retail cartilage capsuleNot automatically the investigational extract

Safety and treatment considerations

Digestive adverse effects have been reported, and a liver-injury case was associated with a supplement. These reports do not provide a precise risk estimate. Shark cartilage should not be used to replace cancer treatment or assumed to be safe because it is animal-derived. [1]

A practical next step

No shark-cartilage brand or dosing strategy is offered. For joint or cancer concerns, focus on options supported for the actual condition and discuss supplements as part of the existing care plan.

Shark cartilage: cancer claims and disappointing clinical results — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Shark Cartilage
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.